Phio Pharmaceuticals Corp.
Calidad de datos: 83%
PHIO
Nasdaq
Manufacturing
Chemicals
$1.26
▼
$0.05
(-3.46%)
Cap. Mercado: 14.58 M
Precio
$1.26
Cap. Mercado
14.58 M
Rango del Día
$1.25 — $1.28
Rango de 52 Semanas
$0.81 — $4.19
Volumen
53,133
Apertura $1.25
Promedio 50D / 200D
$1.15
9.15% above
Promedio 50D / 200D
$1.70
26.05% below
Quick Summary
Puntos Clave
Negative free cash flow of -7.99 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-87.27%
Below sector avg (-51.02%)
ROIC-71.43%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A
Valoración
PE (TTM)
-1.68
Above sector avg (-1.98)
P/B Ratio1.48
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -1.7 | -2.0 |
| P/B | 1.5 | 5.1 |
| ROE % | -87.3 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -8.70 M |
| ROE | -87.27% | ROA | -76.28% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -7.99 M |
| ROIC | -71.43% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | 9.84 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.68 | Forward P/E | N/A |
| P/B Ratio | 1.48 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -54.81% | ||
| Market Cap | 14.58 M | Enterprise Value | 3.87 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0.69 | OCF / Share | -0.69 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 91.87% |
| SBC-Adj. FCF | -8.25 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -8.70 M | -7.15 M | -10.83 M | -11.48 M | -13.29 M |
| EPS (Diluted) | — | -9.08 | -5.20 | -10.10 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -9.22 M | -7.39 M | -10.82 M | -11.46 M | -13.51 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 4.62 M | 3.64 M | 6.33 M | 7.01 M | 8.89 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 3,000.0 | 2,000.0 | 56,000.0 | 71,000.0 | 75,000.0 |
| Interest Expense | — | 231,000.0 | — | — | — |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 21.49 M | 5.74 M | 9.36 M | 12.81 M | 25.17 M |
| Total Liabilities | 1.34 M | 1.02 M | 1.63 M | 1.97 M | 3.24 M |
| Shareholders' Equity | 20.15 M | 4.72 M | 7.73 M | 10.84 M | 21.93 M |
| Total Debt | — | — | — | — | 0.0 |
| Cash & Equivalents | 21.03 M | 5.38 M | — | — | — |
| Current Assets | 21.48 M | 5.74 M | 9.32 M | 12.45 M | 24.73 M |
| Current Liabilities | — | 1.02 M | 1.63 M | 1.94 M | 3.07 M |
{"event":"ticker_viewed","properties":{"ticker":"PHIO","listing_kind":"stock","pathname":"/stocks/phio","exchange":"Nasdaq","country":"US"}}